This conserved lipid acyltransferase has many re-entrant segments but only one true TM helix. Most closely related to bacterial acyltransferases.. Heavily expanded in kinetoplastids for unknown reasons. Localization: ER (by homology)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 27 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 27 |
NetGPI | no | yes: 0, no: 27 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 23 |
GO:0110165 | cellular anatomical entity | 1 | 23 |
Related structures:
AlphaFold database: Q9NF91
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 5 |
GO:0006644 | phospholipid metabolic process | 4 | 5 |
GO:0006650 | glycerophospholipid metabolic process | 5 | 5 |
GO:0006654 | phosphatidic acid biosynthetic process | 6 | 5 |
GO:0006793 | phosphorus metabolic process | 3 | 5 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 5 |
GO:0008152 | metabolic process | 1 | 5 |
GO:0008610 | lipid biosynthetic process | 4 | 5 |
GO:0008654 | phospholipid biosynthetic process | 5 | 5 |
GO:0009058 | biosynthetic process | 2 | 5 |
GO:0009987 | cellular process | 1 | 5 |
GO:0019637 | organophosphate metabolic process | 3 | 5 |
GO:0044237 | cellular metabolic process | 2 | 5 |
GO:0044238 | primary metabolic process | 2 | 5 |
GO:0044249 | cellular biosynthetic process | 3 | 5 |
GO:0044255 | cellular lipid metabolic process | 3 | 5 |
GO:0045017 | glycerolipid biosynthetic process | 4 | 5 |
GO:0046473 | phosphatidic acid metabolic process | 6 | 5 |
GO:0046474 | glycerophospholipid biosynthetic process | 5 | 5 |
GO:0046486 | glycerolipid metabolic process | 4 | 5 |
GO:0071704 | organic substance metabolic process | 2 | 5 |
GO:0090407 | organophosphate biosynthetic process | 4 | 5 |
GO:1901576 | organic substance biosynthetic process | 3 | 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 28 |
GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity | 7 | 5 |
GO:0008374 | O-acyltransferase activity | 5 | 5 |
GO:0016411 | acylglycerol O-acyltransferase activity | 6 | 5 |
GO:0016740 | transferase activity | 2 | 28 |
GO:0016746 | acyltransferase activity | 3 | 28 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 5 |
GO:0042171 | lysophosphatidic acid acyltransferase activity | 6 | 5 |
GO:0071617 | lysophospholipid acyltransferase activity | 5 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 235 | 239 | PF00656 | 0.317 |
CLV_C14_Caspase3-7 | 253 | 257 | PF00656 | 0.189 |
CLV_C14_Caspase3-7 | 362 | 366 | PF00656 | 0.292 |
CLV_MEL_PAP_1 | 222 | 228 | PF00089 | 0.544 |
CLV_NRD_NRD_1 | 19 | 21 | PF00675 | 0.378 |
CLV_NRD_NRD_1 | 213 | 215 | PF00675 | 0.534 |
CLV_NRD_NRD_1 | 344 | 346 | PF00675 | 0.565 |
CLV_NRD_NRD_1 | 64 | 66 | PF00675 | 0.335 |
CLV_PCSK_FUR_1 | 61 | 65 | PF00082 | 0.335 |
CLV_PCSK_KEX2_1 | 19 | 21 | PF00082 | 0.378 |
CLV_PCSK_KEX2_1 | 344 | 346 | PF00082 | 0.573 |
CLV_PCSK_KEX2_1 | 63 | 65 | PF00082 | 0.339 |
CLV_PCSK_PC7_1 | 15 | 21 | PF00082 | 0.382 |
CLV_PCSK_SKI1_1 | 200 | 204 | PF00082 | 0.508 |
DEG_APCC_DBOX_1 | 86 | 94 | PF00400 | 0.451 |
DEG_Nend_UBRbox_4 | 1 | 3 | PF02207 | 0.576 |
DOC_CYCLIN_RxL_1 | 197 | 207 | PF00134 | 0.324 |
DOC_CYCLIN_yCln2_LP_2 | 28 | 34 | PF00134 | 0.544 |
DOC_MAPK_DCC_7 | 133 | 141 | PF00069 | 0.419 |
DOC_MAPK_DCC_7 | 87 | 95 | PF00069 | 0.364 |
DOC_MAPK_gen_1 | 87 | 95 | PF00069 | 0.321 |
DOC_MAPK_MEF2A_6 | 133 | 141 | PF00069 | 0.398 |
DOC_MAPK_MEF2A_6 | 87 | 95 | PF00069 | 0.318 |
DOC_MAPK_MEF2A_6 | 97 | 105 | PF00069 | 0.261 |
DOC_PP1_RVXF_1 | 142 | 149 | PF00149 | 0.346 |
DOC_PP1_RVXF_1 | 165 | 171 | PF00149 | 0.432 |
DOC_PP2B_LxvP_1 | 124 | 127 | PF13499 | 0.583 |
DOC_PP2B_LxvP_1 | 28 | 31 | PF13499 | 0.548 |
DOC_PP2B_LxvP_1 | 32 | 35 | PF13499 | 0.533 |
DOC_PP2B_PxIxI_1 | 150 | 156 | PF00149 | 0.266 |
DOC_USP7_MATH_1 | 371 | 375 | PF00917 | 0.489 |
DOC_WW_Pin1_4 | 194 | 199 | PF00397 | 0.321 |
DOC_WW_Pin1_4 | 20 | 25 | PF00397 | 0.565 |
DOC_WW_Pin1_4 | 375 | 380 | PF00397 | 0.449 |
LIG_14-3-3_CanoR_1 | 167 | 171 | PF00244 | 0.378 |
LIG_14-3-3_CanoR_1 | 19 | 24 | PF00244 | 0.567 |
LIG_14-3-3_CanoR_1 | 278 | 284 | PF00244 | 0.216 |
LIG_BIR_III_4 | 236 | 240 | PF00653 | 0.199 |
LIG_deltaCOP1_diTrp_1 | 307 | 313 | PF00928 | 0.294 |
LIG_EH1_1 | 99 | 107 | PF00400 | 0.221 |
LIG_FHA_1 | 113 | 119 | PF00498 | 0.342 |
LIG_FHA_1 | 126 | 132 | PF00498 | 0.478 |
LIG_FHA_1 | 376 | 382 | PF00498 | 0.352 |
LIG_FHA_1 | 39 | 45 | PF00498 | 0.534 |
LIG_GBD_Chelix_1 | 77 | 85 | PF00786 | 0.394 |
LIG_LIR_Gen_1 | 189 | 199 | PF02991 | 0.280 |
LIG_LIR_Gen_1 | 287 | 296 | PF02991 | 0.266 |
LIG_LIR_LC3C_4 | 115 | 119 | PF02991 | 0.357 |
LIG_LIR_LC3C_4 | 71 | 75 | PF02991 | 0.187 |
LIG_LIR_Nem_3 | 169 | 173 | PF02991 | 0.349 |
LIG_LIR_Nem_3 | 186 | 191 | PF02991 | 0.294 |
LIG_LIR_Nem_3 | 197 | 202 | PF02991 | 0.292 |
LIG_LIR_Nem_3 | 282 | 288 | PF02991 | 0.286 |
LIG_LIR_Nem_3 | 297 | 302 | PF02991 | 0.310 |
LIG_Pex14_2 | 143 | 147 | PF04695 | 0.396 |
LIG_Pex14_2 | 219 | 223 | PF04695 | 0.319 |
LIG_Pex14_2 | 229 | 233 | PF04695 | 0.299 |
LIG_Pex14_2 | 288 | 292 | PF04695 | 0.282 |
LIG_SH2_CRK | 191 | 195 | PF00017 | 0.346 |
LIG_SH2_PTP2 | 83 | 86 | PF00017 | 0.266 |
LIG_SH2_STAT3 | 129 | 132 | PF00017 | 0.221 |
LIG_SH2_STAT5 | 129 | 132 | PF00017 | 0.410 |
LIG_SH2_STAT5 | 180 | 183 | PF00017 | 0.393 |
LIG_SH2_STAT5 | 232 | 235 | PF00017 | 0.263 |
LIG_SH2_STAT5 | 83 | 86 | PF00017 | 0.316 |
LIG_SH3_3 | 23 | 29 | PF00018 | 0.554 |
LIG_SUMO_SIM_anti_2 | 71 | 76 | PF11976 | 0.187 |
LIG_SUMO_SIM_par_1 | 71 | 76 | PF11976 | 0.232 |
LIG_TYR_ITIM | 81 | 86 | PF00017 | 0.397 |
LIG_WRC_WIRS_1 | 280 | 285 | PF05994 | 0.290 |
MOD_CDK_SPxK_1 | 194 | 200 | PF00069 | 0.340 |
MOD_CK1_1 | 112 | 118 | PF00069 | 0.372 |
MOD_CK1_1 | 22 | 28 | PF00069 | 0.553 |
MOD_CMANNOS | 310 | 313 | PF00535 | 0.585 |
MOD_Cter_Amidation | 61 | 64 | PF01082 | 0.334 |
MOD_GlcNHglycan | 111 | 114 | PF01048 | 0.360 |
MOD_GlcNHglycan | 162 | 166 | PF01048 | 0.542 |
MOD_GlcNHglycan | 177 | 180 | PF01048 | 0.374 |
MOD_GlcNHglycan | 260 | 263 | PF01048 | 0.527 |
MOD_GlcNHglycan | 367 | 370 | PF01048 | 0.602 |
MOD_GSK3_1 | 171 | 178 | PF00069 | 0.342 |
MOD_GSK3_1 | 204 | 211 | PF00069 | 0.316 |
MOD_GSK3_1 | 365 | 372 | PF00069 | 0.334 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.573 |
MOD_NEK2_1 | 161 | 166 | PF00069 | 0.424 |
MOD_NEK2_1 | 202 | 207 | PF00069 | 0.270 |
MOD_NEK2_1 | 208 | 213 | PF00069 | 0.306 |
MOD_NEK2_1 | 73 | 78 | PF00069 | 0.353 |
MOD_PIKK_1 | 171 | 177 | PF00454 | 0.260 |
MOD_PIKK_1 | 38 | 44 | PF00454 | 0.531 |
MOD_PKA_1 | 19 | 25 | PF00069 | 0.567 |
MOD_PKA_2 | 166 | 172 | PF00069 | 0.368 |
MOD_PKA_2 | 19 | 25 | PF00069 | 0.564 |
MOD_Plk_1 | 306 | 312 | PF00069 | 0.359 |
MOD_Plk_4 | 104 | 110 | PF00069 | 0.326 |
MOD_Plk_4 | 183 | 189 | PF00069 | 0.282 |
MOD_Plk_4 | 287 | 293 | PF00069 | 0.328 |
MOD_Plk_4 | 295 | 301 | PF00069 | 0.328 |
MOD_Plk_4 | 68 | 74 | PF00069 | 0.479 |
MOD_ProDKin_1 | 194 | 200 | PF00069 | 0.321 |
MOD_ProDKin_1 | 20 | 26 | PF00069 | 0.563 |
MOD_ProDKin_1 | 375 | 381 | PF00069 | 0.454 |
MOD_SUMO_rev_2 | 333 | 342 | PF00179 | 0.349 |
MOD_SUMO_rev_2 | 356 | 366 | PF00179 | 0.282 |
TRG_ENDOCYTIC_2 | 191 | 194 | PF00928 | 0.363 |
TRG_ENDOCYTIC_2 | 285 | 288 | PF00928 | 0.317 |
TRG_ENDOCYTIC_2 | 299 | 302 | PF00928 | 0.292 |
TRG_ENDOCYTIC_2 | 354 | 357 | PF00928 | 0.387 |
TRG_ENDOCYTIC_2 | 83 | 86 | PF00928 | 0.383 |
TRG_ER_diArg_1 | 343 | 345 | PF00400 | 0.398 |
TRG_ER_diArg_1 | 61 | 64 | PF00400 | 0.534 |
TRG_ER_diArg_1 | 86 | 89 | PF00400 | 0.410 |
TRG_NES_CRM1_1 | 322 | 335 | PF08389 | 0.301 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P455 | Leptomonas seymouri | 55% | 100% |
A0A0N1HTP4 | Leptomonas seymouri | 64% | 100% |
A0A0N1I6V1 | Leptomonas seymouri | 35% | 100% |
A0A0N1IKX5 | Leptomonas seymouri | 35% | 100% |
A0A0S4IQ05 | Bodo saltans | 32% | 100% |
A0A0S4IR22 | Bodo saltans | 42% | 100% |
A0A0S4JRB2 | Bodo saltans | 30% | 100% |
A0A1X0P9F0 | Trypanosomatidae | 34% | 100% |
A0A3R7NKA0 | Trypanosoma rangeli | 34% | 100% |
A0A3S5H5E4 | Leishmania donovani | 89% | 89% |
A0A3S5H7L8 | Leishmania donovani | 35% | 100% |
A0A3S7WNW6 | Leishmania donovani | 51% | 100% |
A4H419 | Leishmania braziliensis | 68% | 100% |
A4H420 | Leishmania braziliensis | 55% | 100% |
A4HHM7 | Leishmania braziliensis | 33% | 100% |
A4HSA1 | Leishmania infantum | 93% | 100% |
A4HSA2 | Leishmania infantum | 51% | 100% |
A4I4U1 | Leishmania infantum | 30% | 100% |
A4I4U2 | Leishmania infantum | 36% | 100% |
C9ZLI8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 37% | 100% |
E9AE89 | Leishmania major | 30% | 100% |
E9AE90 | Leishmania major | 35% | 100% |
E9AK86 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 53% | 100% |
E9ALJ6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 36% | 100% |
Q9NF90 | Leishmania major | 53% | 100% |
V5C201 | Trypanosoma cruzi | 32% | 100% |